Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19 - Implementation of the scheme and management of supply

This alert provides information on medicine supply, access criteria, data collection and implementation.

SPS commentary:

An accompanying positive scientific opinion includes a public assessment report, a treatment protocol for healthcare professionals, for patients and on the pharmacovigilance system.


Medicines and Healthcare products Regulatory Agency

Resource links:

Early access to medicines scheme scientific opinion: